Clinical Trial Update: Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to evaluate albuminuria reduction with Survodutide in chronic kidney disease, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Survodutide (BI456906)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Chronic Kidney Disease | Phase 2 | Status: NOT_YET_RECRUITING